Laboratorios Farmaceuticos Rovi
ROVI.MC
#3670
Rank
A$5.34 B
Marketcap
A$104.60
Share price
-4.54%
Change (1 day)
-0.43%
Change (1 year)

Earnings for Laboratorios Farmaceuticos Rovi (ROVI.MC)

Earnings in 2026 (TTM): A$0.41 Billion

According to Laboratorios Farmaceuticos Rovi's latest financial reports the company's current earnings are A$0.89 Billion. In 2025 the company made an earning of A$0.32 Billion a decrease over its 2024 earnings that were of A$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Laboratorios Farmaceuticos Rovi from 2010 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.41 B25.77%
2025 A$0.32 B-25.47%
2024 A$0.43 B-8.41%
2023 A$0.47 B15.62%
2022 A$0.41 B29.09%
2021 A$0.32 B149.21%
2020 A$0.12 B79.92%
2019 A$71.47 M128.6%
2018 A$31.26 M0.14%
2017 A$31.22 M-35.41%
2016 A$48.34 M28.52%
2015 A$37.61 M-32.56%
2014 A$55.77 M8.45%
2013 A$51.42 M-4.24%
2012 A$53.7 M2.62%
2011 A$52.33 M-3.29%
2010 A$54.11 M